"<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<xml><records>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>1<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Seth Flaxman<\/author><author>Rupert Bourne<\/author><author>Serge Resnikoff et al.<\/author><\/authors><\/contributors><titles><title>Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis<\/title><secondary-title>The Lancet Global Health<\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.1016\/s2214-109x(17)30393-5<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S2214109X17303935\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Maximilian Huhn<\/author><author>Adriani Nikolakopoulou<\/author><author>Johannes Schneider\u2010Thoma et al.<\/author><\/authors><\/contributors><titles><title>Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(19)31135-3<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S0140673619311353\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Valery L. Feigin<\/author><author>Benjamin A. Stark<\/author><author>Catherine Owens Johnson et al.<\/author><\/authors><\/contributors><titles><title>Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019<\/title><secondary-title>The Lancet Neurology<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1016\/s1474-4422(21)00252-0<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S1474442221002520\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Lale Say<\/author><author>Doris Chou<\/author><author>Alison Gemmill et al.<\/author><\/authors><\/contributors><titles><title>Global causes of maternal death: a WHO systematic analysis<\/title><secondary-title>The Lancet Global Health<\/secondary-title><\/titles><dates><year>2014<\/year><\/dates><electronic-resource-num>10.1016\/s2214-109x(14)70227-x<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S2214109X1470227X\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gregory A. Roth<\/author><author>Degu Abate<\/author><author>Kalkidan Hassen Abate et al.<\/author><\/authors><\/contributors><titles><title>Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(18)32203-7<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S0140673618322037\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Achim Rittmeyer<\/author><author>Fabrice Barl\u00e9si<\/author><author>Daniel Waterkamp et al.<\/author><\/authors><\/contributors><titles><title>Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(16)32517-x<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/pmc6886121?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Tao Chen<\/author><author>Di Wu<\/author><author>Huilong Chen et al.<\/author><\/authors><\/contributors><titles><title>Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study<\/title><secondary-title>BMJ<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1136\/bmj.m1091<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.bmj.com\/content\/bmj\/368\/bmj.m1091.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bin Zhou<\/author><author>Yuan Lu<\/author><author>Kaveh Hajifathalian et al.<\/author><\/authors><\/contributors><titles><title>Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(16)00618-8<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S0140673616006188\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Antonio Ayala<\/author><author>Mario Mu\u00f1oz<\/author><author>Sandro Arg\u00fcelles<\/author><\/authors><\/contributors><titles><title>Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal<\/title><secondary-title>Oxidative Medicine and Cellular Longevity<\/secondary-title><\/titles><dates><year>2014<\/year><\/dates><electronic-resource-num>10.1155\/2014\/360438<\/electronic-resource-num><urls><related-urls><url>https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1155\/2014\/360438<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gary M. Clifford<\/author><author>Jennifer Susan Smith<\/author><author>Martyn Plummer et al.<\/author><\/authors><\/contributors><titles><title>Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis<\/title><secondary-title>British Journal of Cancer<\/secondary-title><\/titles><dates><year>2003<\/year><\/dates><electronic-resource-num>10.1038\/sj.bjc.6600688<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/6600688.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>David S. Hong<\/author><author>Marwan Fakih<\/author><author>John H. Strickler et al.<\/author><\/authors><\/contributors><titles><title>KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors<\/title><secondary-title>New England Journal of Medicine<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1056\/nejmoa1917239<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/7571518<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Rupert Bourne<\/author><author>Gretchen A Stevens<\/author><author>Richard Aubrey White et al.<\/author><\/authors><\/contributors><titles><title>Causes of vision loss worldwide, 1990\u20132010: a systematic analysis<\/title><secondary-title>The Lancet Global Health<\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1016\/s2214-109x(13)70113-x<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S2214109X1370113X\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Longfei Jia<\/author><author>Yifeng Du<\/author><author>Lan Chu et al.<\/author><\/authors><\/contributors><titles><title>Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study<\/title><secondary-title>The Lancet Public Health<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1016\/s2468-2667(20)30185-7<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S2468266720301857\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Annemarie Beth Docherty<\/author><author>Ewen Munro Harrison<\/author><author>Christopher Aird Green et al.<\/author><\/authors><\/contributors><titles><title>Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study<\/title><secondary-title>BMJ<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1136\/bmj.m1985<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.bmj.com\/content\/bmj\/369\/bmj.m1985.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Huang YS<\/author><author>Wu SD<\/author><author>Chen HC et al.<\/author><\/authors><\/contributors><titles><title>Melatonin receptor signaling in human pathologies: from molecular mechanisms to therapeutic targets.<\/title><secondary-title>Function (Oxford, England)<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1152\/function.011.2026<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1152\/function.011.2026<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>David T. Felson<\/author><author>Allan Naimark<\/author><author>Jennifer J. Anderson et al.<\/author><\/authors><\/contributors><titles><title>The prevalence of knee osteoarthritis in the elderly. the framingham osteoarthritis study<\/title><secondary-title>Arthritis &amp; Rheumatism<\/secondary-title><\/titles><dates><year>1987<\/year><\/dates><electronic-resource-num>10.1002\/art.1780300811<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Martin Magnuson<\/author><author>Lina Tengdelius<\/author><author>Fredrik Eriksson et al.<\/author><\/authors><\/contributors><titles><title>Reactive magnetron sputtering of tungsten target in krypton\/trimethylboron atmosphere<\/title><secondary-title>arXiv (1909.07197v1)<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.1016\/j.tsf.2019.06.034<\/electronic-resource-num><urls><related-urls><url>https:\/\/arxiv.org\/abs\/1909.07197v1<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kozhokaru AB<\/author><author>Shmyrev VI<\/author><author>Lebedeva DI et al.<\/author><\/authors><\/contributors><titles><title>[Sleep disorders and oxidative stress].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.17116\/jnevro202612605268<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Guruswamy Pandian AP<\/author><author>Natarajan A<\/author><author>Mathai B et al.<\/author><\/authors><\/contributors><titles><title>Sleep Disorders: Management by Alternative Therapies.<\/title><secondary-title>The Medical clinics of North America<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1016\/j.mcna.2026.01.013<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Waight E<\/author><author>Zhu Y<\/author><author>Caudell A et al.<\/author><\/authors><\/contributors><titles><title>Chronotherapy to reinforce circadian rhythms improves poststroke outcomes and glymphatic function in mice.<\/title><secondary-title>The Journal of clinical investigation<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1172\/JCI201800<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1172\/jci201800<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"